Open Access
Current Psychiatry Reports, volume 23, issue 2, publication number 8
The Impact of the Menstrual Cycle and Underlying Hormones in Anxiety and PTSD: What Do We Know and Where Do We Go From Here?
Yael I. Nillni
1, 2
,
Ann M. Rasmusson
1, 2
,
Emilie L Paul
3
,
Suzanne L Pineles
1, 2
1
National Center for PTSD, Women’s Health Sciences Division at VA Boston Healthcare System, Boston, USA
|
3
Department of Psychiatry, Boston Medical Center, Boston, USA
|
Publication type: Journal Article
Publication date: 2021-01-06
Journal:
Current Psychiatry Reports
scimago Q1
SJR: 2.151
CiteScore: 11.3
Impact factor: 5.5
ISSN: 15233812, 15351645
PubMed ID:
33404887
Psychiatry and Mental health
Abstract
This paper reviews the recent literature on menstrual cycle phase effects on outcomes relevant to anxiety and PTSD, discusses potential neurobiological mechanisms underlying these effects, and highlights methodological limitations impeding scientific advancement. The menstrual cycle and its underlying hormones impact symptom expression among women with anxiety and PTSD, as well as psychophysiological and biological processes relevant to anxiety and PTSD. The most consistent findings are retrospective self-report of premenstrual exacerbation of anxiety symptoms and the protective effect of estradiol on recall of extinction learning among healthy women. Lack of rigorous methodology for assessing menstrual cycle phase and inconsistent menstrual cycle phase definitions likely contribute to other conflicting results. Further investigations that address these limitations and integrate complex interactions between menstrual cycle phase–related hormones, genetics, and psychological vulnerabilities are needed to inform personalized prevention and intervention efforts for women.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.